α-Adrenoceptor subclassification

  • Klaus Starke
Part of the Reviews of Physiology, Biochemistry and Pharmacology book series (volume 88)


Noradrenergic Neurone Potency Ratio Presynaptic Receptor Sympathetic Nerve Stimulation Noradrenaline Neurone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aktories K, Schultz G, Jakobs KH (1980) Regulation of adenylate cyclase activity in hamster adipocytes. Inhibition by prostaglandins, α-adrenergic agonists and nicotinic acid. Naunyn Schmiedebergs Arch Pharmacol 312:167–173CrossRefPubMedGoogle Scholar
  2. Algate DR, Waterfall JF (1978) Action of indoramin on pre-and postsynaptic α-adrenoceptors in pithed rats. J Pharm Pharmacol 30:651–652PubMedGoogle Scholar
  3. Andén NE, Corrodi H, Fuxe K, Hökfelt B, Hökfelt T, Rydin C, Svensson T (1970) Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci 9/I:513–523CrossRefGoogle Scholar
  4. Andén NE, Grabowska M, Strömbom U (1976) Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents. Naunyn Schmiedebergs Arch Pharmacol 292:43–52CrossRefPubMedGoogle Scholar
  5. Andén NE, Gomes C, Persson B, Trolin G (1978) R 28935 and prazosin: effects on central and peripheral alpha-adrenoreceptor activity and on blood pressure. Naunyn Schmiedebergs Arch Pharmacol 302:299–306CrossRefPubMedGoogle Scholar
  6. Andréjak M, Pommier Y, Mouillé P, Schmitt H (in press) Effects of some α-adrenoceptor agonists and antagonists on the guinea-pig ileum. Naunyn Schmiedebergs Arch PharmacolGoogle Scholar
  7. Ariens EJ (ed) (1964) Molecular pharmacology, vol 1. Academic Press, New YorkGoogle Scholar
  8. Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48–58Google Scholar
  9. Bacq ZM (1935) Recherches sur la physiologie et la pharmacologie du système nerveux autonome. Arch Int Pharmacodyn Thér 52:471–492Google Scholar
  10. Barnes P, Karliner J, Hamilton C, Dollery C (1979) Demonstration of α1-adrenoceptors in guinea pig lung using 3H-prazosin. Life Sci 25:1207–1214CrossRefPubMedGoogle Scholar
  11. Berthelsen S, Pettinger WA (1977) A functional basis for classification of α-adrenergic receptors. Life Sci 21:595–606CrossRefPubMedGoogle Scholar
  12. Besse JC, Furchgott RF (1976) Dissociation constants and relative efficacies of agonists acting on alpha adrenergic receptors in rabbit aorta. J Pharmacol Exp Ther 197:66–78PubMedGoogle Scholar
  13. Blakeley AGH, Summers RJ (1977) The effects of labetalol (AH 5158) on adrenergic transmission in the cat spleen. Br J Pharmacol 59:643–650PubMedGoogle Scholar
  14. Blakeley AGH, Summers RJ (1978) The effects of piperoxan on uptake of noradrenaline and overflow of transmitter in the isolated blood perfused spleen of the cat. Br J Pharmacol 63:683–687PubMedGoogle Scholar
  15. Borowski E, Starke K, Ehrl H, Endo T (1977) A comparison of pre-and postsynaptic effects of α-adrenolytic drugs in the pulmonary artery of the rabbit. Neuroscience 2:285–296CrossRefPubMedGoogle Scholar
  16. Brown DA, Caulfield MP (1979) Hyperpolarizing ‘α2'-adrenoceptors in rat sympathetic ganglia. Br J Pharmacol 65:435–445PubMedGoogle Scholar
  17. Butler M, Jenkinson DH (1978) Blockade by WB 4101 of α-adrenoceptors in the rat vas deferens and guinea-pig taenia caeci. Eur J Pharmacol 52:303–311CrossRefPubMedGoogle Scholar
  18. Cambridge D, Davey MJ, Massingham R (1977) Prazosin, a selective antagonist of post-synaptic α-adrenoceptors. Br J Pharmacol 59:514P–515PGoogle Scholar
  19. Cavero I, Lefèvre F, Roach A (1977) Further studies on cardiovascular effects of prazosin (P). Fed Proc 36:955Google Scholar
  20. Cavero I, Dennis T, Lefèvre-Borg F, Perrot P, Roach AG, Scatton B (1979a) Effects of clonidine, prazosin and phentolamine on heart rate and coronary sinus catecholamine concentration during cardioaccelerator nerve stimulation in spinal dogs. Br J Pharmacol 67:283–292PubMedGoogle Scholar
  21. Cavero I, Gomeni R, Lefèvre-Borg F, Roach AG (1979b) Effects of mianserin on noradrenaline uptake, cardiac presynaptic and vascular postsynaptic α-adrenoceptors in rats. Br J Pharmacol 66:132P–133PPubMedGoogle Scholar
  22. Cedarbaum JM, Aghajanian GK (1977) Catecholamine receptors on locus coeruleus neurons: pharmacological characterization. Eur J Pharmacol 44:375–385CrossRefPubMedGoogle Scholar
  23. Clineschmidt BV, Flataker LM, Faison E, Holmes R (1979) An in vivo model for investigating α1-and α2-receptors in the CNS: studies with mianserin. Arch Int Pharmacodyn Thér 242:59–76Google Scholar
  24. Clineschmidt BV, Flataker LM, Faison EP, Haubrich DR (1980) α-Methyldopa reduces locomotor activity in rats via its metabolite, α-methylnorepinephrine, acting on α2-adrenoceptors. Arch Int Pharmacodyn Thér 244:231–243Google Scholar
  25. Constantine JW, Lebel W (in press) Irreversible blockade by phenoxybenzamine of α1-but not of α2-vascular receptors in dogs and the effects of propranolol. Naunyn Schmiedebergs Arch PharmacolGoogle Scholar
  26. Constantine JW, Weeks RA, McShane WK (1978) Prazosin and presynaptic α-receptors in the cardioaccelerator nerve of the dog. Eur J Pharmacol 50:51–60CrossRefPubMedGoogle Scholar
  27. Constantine JW, Gunnell D, Weeks RA (1980) α1-and α2-vascular adrenoceptors in the dog. Eur J Pharmacol 66:281–286CrossRefPubMedGoogle Scholar
  28. Cubeddu L, Barnes EM, Langer SZ, Weiner N (1974) Release of norepinephrine and dopamine-β-hydroxylase by nerve stimulation. I. Role of neuronal and extraneuronal uptake and of alpha presynaptic receptors. J Pharmacol Exp Ther 190:431–450PubMedGoogle Scholar
  29. Davis JN, Arnett CD, Hoyler E, Stalvey LP, Daly JW, Skolnick P (1978) Brain α-adrenergic receptors: comparison of (3H)WB 4101 binding with norepinephrine-stimulated cyclic AMP accumulation in rat cerebral cortex. Brain Res 159:125–135CrossRefPubMedGoogle Scholar
  30. Davis M, Redmond DE, Baraban JM (1979) Noradrenergic agonists and antagonists: effects on conditioned fear as measured by the potentiated startle paradigm. Psychopharmacology (Berlin) 65:111–118Google Scholar
  31. Deck R, Oberdorf A, Kroneberg G (1971) Die Wirkung von 2-(2,6-Dichlorphenylamino)-2-imidazolin-Hydrochlorid (Clonidin) auf die Kontraktion und die Acetylcholin-Freisetzung am isolierten, koaxial elektrisch gereizten Meerschweinchenileum. Arzneim Forsch 21:1580–1584Google Scholar
  32. Delbarre B, Schmitt H (1969) Influences pharmacologiques exercées sur la durée du sommeil provoqué chez le poussin par la 2-(2,6-dichlorophénylamino)-2-imidazoline (St 155, Catapresan). CR Soc Biol (Paris) 163:1922–1926Google Scholar
  33. Delbarre B, Schmitt H (1971) Sedative effects of α-sympathomimetic drugs and their antagonism by adrenergic and cholinergic blocking drugs. Eur J Pharmacol 13:356–363CrossRefPubMedGoogle Scholar
  34. Delbarre B, Schmitt H (1973) A further attempt to characterize sedative receptors activated by clonidine in chickens and mice. Eur J Pharmacol 22:355–359CrossRefPubMedGoogle Scholar
  35. Delini-Stula A, Baumann P, Büch O (1979) Depression of exploratory activity by clonidine in rats as a model for the detection of relative pre-and postsynaptic central noradrenergic receptor selectivity of α-adrenolytic drugs. Naunyn Schmiedebergs Arch Pharmacol 307:115–122CrossRefPubMedGoogle Scholar
  36. De Mey JG, Vanhoutte PM (1980) Differences in pharmacological properties of post-junctional alpha-adrenergic receptors among arteries and veins. Arch Int Pharmacodyn Thér 244:328–329Google Scholar
  37. Docherty JR, McGrath JC (1980) A comparison of pre-and post-junctional potencies of several alpha-adrenoceptor agonists in the cardiovascular system and anococcygeus of the rat. Evidence for two types of post-junctional alpha-adrenoceptor. Naunyn Schmiedebergs Arch Pharmacol 312:107–116CrossRefPubMedGoogle Scholar
  38. Docherty JR, MacDonald A, McGrath JC (1979) Further sub-classification of α-adrenoceptors in the cardiovascular system, vas deferens and anococcygeus of the rat. Br J Pharmacol 67:421P–422PPubMedGoogle Scholar
  39. Doxey JC (1979) Pre-and postsynaptic effects of α-agonists in the anococcygeus muscle of the pithed rat. Eur J Pharmacol 54:185–189CrossRefPubMedGoogle Scholar
  40. Doxey JC, Everitt J (1977) Inhibitory effects of clonidine on responses to sympathetic nerve stimulation in the pithed rat. Br J Pharmacol 61:559–566PubMedGoogle Scholar
  41. Doxey JC, Everitt J, Metcalf G (1978) Mianserin — an analysis of its peripheral autonomic actions. Eur J Pharmacol 51:1–10CrossRefPubMedGoogle Scholar
  42. Doxey JC, Smith CFC, Walker JM (1977) Selectivity of blocking agents for pre-and postsynaptic α-adrenoceptors. Br J Pharmacol 60:91–96PubMedGoogle Scholar
  43. Drew GM (1976) Effects of α-adrenoceptor agonists and antagonists on pre-and post-synaptically located α-adrenoceptors. Eur J Pharmacol 36:313–320CrossRefPubMedGoogle Scholar
  44. Drew GM (1977a) Pharmacological characterization of presynaptic α-adrenoceptors which regulate cholinergic activity in the guinea-pig ileum. Br J Pharmacol 59:513PGoogle Scholar
  45. Drew GM (1977b) Pharmacological characterisation of the presynaptic α-adrenoceptors in the rat vas deferens. Eur J Pharmacol 42:123–130CrossRefPubMedGoogle Scholar
  46. Drew GM (1978) Pharmacological characterization of the presynaptic α-adrenoceptors regulating cholinergic activity in the guinea-pig ileum. Br J Pharmacol 64:293–300PubMedGoogle Scholar
  47. Drew GM (1979) Presynaptic α-adrenoceptors: their pharmacological characterisation and functional significance. In: Langer SZ, Starke K, Dubocovich ML (eds) Presynaptic receptors. Pergamon Press, Oxford, pp 59–65Google Scholar
  48. Drew GM (1980) Postsynaptic α2-adrenoceptors mediate pressor responses to 2-N,N-dimethylamino-5,6-dihydroxy-1,2,3,4-tetrahydronaphthalene (M-7). Eur J Pharmacol 65:85–87CrossRefPubMedGoogle Scholar
  49. Drew GM, Whiting SB (1979) Evidence for two distinct types of postsynaptic α-adrenceptor in vascular smooth muscle in vivo. Br J Pharmacol 67:207–215PubMedGoogle Scholar
  50. Drew GM, Gower AJ, Marriott AS (1979) α2-Adrenoceptors mediate clonidine-induced sedation in the rat. Br J Pharmacol 67:133–141PubMedGoogle Scholar
  51. Dubocovich ML (1979) Pharmacological differences between the alpha-presynaptic adrenoceptors in the peripheral and the central nervous systems. In: Langer SZ, Starke K, Dubocovich ML (eds) Presynaptic receptors. Pergamon Press, Oxford, pp 29–36Google Scholar
  52. Dubocovich ML, Langer SZ (1974) Negative feed-back regulation of noradrenaline release by nerve stimulation in the perfused cat's spleen: differences in potency of phenoxybenzamine in blocking the pre-and post-synaptic adrenergic receptors. J Physiol (Lond) 237:505–519PubMedGoogle Scholar
  53. Dubocovich ML, Langer SZ, Massingham R (1980) Lack of correlation between presynaptic inhibition of noradrenaline release and end organ responses during nerve stimulation. Br J Pharmacol 69:81–90PubMedGoogle Scholar
  54. Endo T, Starke K, Bangerter A, Taube HD (1977) Presynaptic receptor systems on the noradrenergic neurones of the rabbit pulmonary artery. Naunyn Schmiedebergs Arch Pharmacol 296:229–247CrossRefPubMedGoogle Scholar
  55. Ennis C, Janssen PAJ, Schnieden H, Cox B (1979) Characterization of receptors on postganglionic cholinergic neurons in the guinea-pig isolated ileum. J Pharm Pharmacol 31:217–221PubMedGoogle Scholar
  56. Flavahan NA, McGrath JC (1980) Blockade by yohimbine of prazosin-resistant pressor effects of adrenaline in the pithed rat. Br J Pharmacol 69:355–357PubMedGoogle Scholar
  57. Franklin KBJ, Herberg LJ (1977) Presynaptic α-adrenoceptors: the depression of self-stimulation by clonidine and its restoration by piperoxane but not by phentolamine or phenoxybenzamine. Eur J Pharmacol 43:33–38CrossRefPubMedGoogle Scholar
  58. Fügner A (1971) Antagonism of the drug induced behavioural sleep in chicks. Arzneim Forsch 21:1350–1352Google Scholar
  59. Fügner A, Hoefke W (1971) A sleep-like state in chicks caused by biogenic amines and other compounds; quantitative evaluation. Arzneim Forsch 21:1243–1247Google Scholar
  60. Fuller RW, Snoddy HD, Marshall WS (1977) Lowering of rat brain 3-methoxy-4-hydroxyphenylethylene glycol sulphate (MOPEG sulphate) concentration by 2,6-dichlorobenzylidene aminoguanidine. J Pharm Pharmacol 29:375–376PubMedGoogle Scholar
  61. Furchgott RF (1964) Receptor mechanisms. Annu Rev Pharmacol 4:21–50CrossRefGoogle Scholar
  62. Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blaschko H, Muscholl E (eds) Catecholamines. Springer, Berlin Heidelberg New York, pp 283–335Google Scholar
  63. Glossmann H, Hornung R (1980) Sodium ions increase the affinity of clonidine for α1-adrenoceptors in rat brain. Naunyn Schmiedebergs Arch Pharmacol 312:105–106CrossRefPubMedGoogle Scholar
  64. Glossmann H, Presek P (1979) Alpha noradrenergic receptors in brain membranes: sodium, magnesium and guanyl nucleotides modulate agonist binding. Naunyn Schmiedebergs Arch Pharmacol 306:67–73CrossRefPubMedGoogle Scholar
  65. Glusa E, Markwardt F, Barthel W (1979) Studies on the inhibition of adrenaline-induced aggregation of blood platelets. Pharmacology 19:196–201PubMedGoogle Scholar
  66. Göthert M, Lox HJ, Rieckesmann JM (1977) Effects of butyrophenones on the sympathetic nerves of the isolated rabbit heart and on the postsynaptic α-adrenoceptors of the isolated rabbit aorta. Naunyn Schmiedebergs Arch Pharmacol 300:255–265PubMedGoogle Scholar
  67. Gold MS, Redmond DE, Kleber HD (1978) Clonidine blocks acute opiate-withdrawal symptoms. Lancet II:599–602CrossRefGoogle Scholar
  68. Grant JA, Scrutton MC (1979) Novel α2-adrenoreceptors primarily responsible for inducing human platelet aggregation. Nature 277:659–661CrossRefGoogle Scholar
  69. Green GJ, Wilson H, Yates MS (1979) The mechanism of the clonidine-induced reduction in peripheral parasympathetic submaxillary salivation. Eur J Pharmacol 56:331–336CrossRefPubMedGoogle Scholar
  70. Greenberg DA, Snyder SH (1978) Pharmacological properties of (3H)dihydroergokryptine binding sites associated with alpha noradrenergic receptors in rat brain membranes. Mol Pharmacol 14:38–49PubMedGoogle Scholar
  71. Greenberg DA, U'Prichard DC, Snyder SH (1976) Alpha-noradrenergic receptor binding in mammalian brain: differential labeling of agonist and antagonist states. Life Sci 19:69–76CrossRefPubMedGoogle Scholar
  72. Greenberg DA, U'Prichard DC, Sheehan P, Snyder SH (1978) α-Noradrenergic receptors in the brain: differential effects of sodium on binding of (3H)agonists and (3H)antagonists. Brain Res 140:378–384CrossRefPubMedGoogle Scholar
  73. Greengrass P, Bremner R (1979) Binding characteristics of 3H-prazosin to rat brain α-adrenergic receptors. Eur J Pharmacol 55:323–326CrossRefPubMedGoogle Scholar
  74. Haeusler G (1974) Clonidine-induced inhibition of sympathetic nerve activity: no indication for a central presynaptic or an indirect sympathomimetic mode of action. Naunyn Schmiedebergs Arch Pharmacol 286:97–111CrossRefGoogle Scholar
  75. Haeusler G (1976) Studies on the possible contribution of a peripheral presynaptic action of clonidine and dopamine to their vascular effects under in vivo conditions. Naunyn Schmiedebergs Arch Pharmacol 295:191–202CrossRefPubMedGoogle Scholar
  76. Hardey DW, Lokhandwala MF (1979) Influence of prazosin on cardiac reflex function. Eur J Pharmacol 57:251–254CrossRefPubMedGoogle Scholar
  77. Harper B, Hughes IE, Stott J (1979) Possible differences in α-adrenoceptors in rat, guinea-pig and rabbit spleen. J Pharm Pharmacol 31:105–107PubMedGoogle Scholar
  78. Hawkins M, Monti JM (1979) Effects of pretreatment with 6-hydroxydopamine or noradrenergic receptor blockers on the clonidine-induced disruption of conditioned avoidance responding. Eur J Pharmacol 58:53–58CrossRefPubMedGoogle Scholar
  79. Heise A, Kroneberg G (1970) Periphere und zentrale Kreislaufwirkung des α-Sympathicomimeticums 2-(2,6-Xylidino)-5,6-dihydro-4H-1,3-thiazinhydrochlorid (BAY 1470). Naunyn Schmiedebergs Arch Pharmakol 266:350–351CrossRefPubMedGoogle Scholar
  80. Heise A, Kroneberg G (1973) Central nervous α-adrenergic receptors and the mode of action of α-methyldopa. Naunyn Schmiedebergs Arch Pharmacol 279:285–300CrossRefPubMedGoogle Scholar
  81. Hicks PE, Cannon JG (1979) NN-Dialkyl derivatives of 2-amino-5,6-dihydroxy-1,2,3,4-tetrahydronaphthalene as selective agonists at presynaptic α-adrenoceptors in the rat. J Pharm Pharmacol 31:494–496PubMedGoogle Scholar
  82. Hieble JP, Pendleton RG (1979) Effects of ring substitution on the pre-and postjunctional alpha-adrenergic activity of aryliminoimidazolidines. Naunyn Schmiedebergs Arch Pharmacol 309:217–224CrossRefPubMedGoogle Scholar
  83. Hoffman BB, de Lean A, Wood CL, Schocken DD, Lefkowitz RJ (1979) Alpha-adrenergic receptor subtypes: quantitative assessment by ligand binding. Life Sci 24:1739–1746CrossRefPubMedGoogle Scholar
  84. Hornung R, Presek P, Glossmann H (1979) Alpha adrenoceptors in rat brain: direct identification with prazosin. Naunyn Schmiedebergs Arch Pharmacol 308:223–230CrossRefPubMedGoogle Scholar
  85. Hoyer I, van Zwieten PA (1971) The centrally induced fall in blood pressure after the infusion of amphetamine and related drugs into the vertebral artery of the cat. J Pharm Pharmacol 23:892–893PubMedGoogle Scholar
  86. Hsu CY, Knapp DR, Halushka PV (1979) The effects of alpha adrenergic agents on human platelet aggregation. J Pharmacol Exp Ther 208:366–370PubMedGoogle Scholar
  87. Hunt GE, Atrens DM, Becker FT, Paxinos G (1978) α-Adrenergic modulation of hypothalamic self-stimulation: effects of phenoxybenzamine, yohimbine, dexamphetamine and their interactions with clonidine. Eur J Pharmacol 53:1–8CrossRefPubMedGoogle Scholar
  88. Jakobs KH, Saur W, Schultz G (1978) Characterization of α-and β-adrenergic receptors linked to human platelet adenylate cyclase. Naunyn Schmiedebergs Arch Pharmacol 302:285–291CrossRefPubMedGoogle Scholar
  89. Jarrott B, Louis WJ, Summers RJ (1979) The characteristics of (3H)-clonidine binding to an α-adrenoceptor in membranes from guinea-pig kidney. Br J Pharmacol 65:663–670PubMedGoogle Scholar
  90. Jauernig RA, Moulds RFW, Shaw J (1978) The action of prazosin in human vascular preparations. Arch Int Pharmacodyn 231:81–89PubMedGoogle Scholar
  91. Johansson B, Johansson SR, Ljung B, Stage L (1972) A receptor kinetic model of a vascular neuroeffector. J Pharmacol Exp Ther 180:636–646PubMedGoogle Scholar
  92. Kapur H, Mottram DR (1978) A comparative study on the pre-and post-synaptic alpha blocking activity of a series of benzodioxanes. Biochem Pharmacol 27:1879–1880CrossRefPubMedGoogle Scholar
  93. Kilbinger H, Wessler I (1979) Increase by α-adrenolytic drugs of acetylcholine release evoked by field stimulation of the guinea-pig ileum. Naunyn Schmiedebergs Arch Pharmacol 309:255–257CrossRefPubMedGoogle Scholar
  94. Kobinger W (1978) Central α-adrenergic systems as targets for hypotensive drugs. Rev Physiol Biochem Pharmacol 81:39–100PubMedGoogle Scholar
  95. Kobinger W, Pichler L (1974) Evidence for direct α-adrenoceptor stimulation of effector neurons in cardiovascular centers by clonidine. Eur J Pharmacol 27:151–154CrossRefPubMedGoogle Scholar
  96. Kobinger W, Pichler L (1980) Investigation into different types of post-and presynaptic α-adrenoceptors at cardiovascular sites in rats. Eur J Pharmacol 65:393–402CrossRefPubMedGoogle Scholar
  97. Kobinger W, Walland A (1971) Involvement of adrenergic receptors in central vagus activity. Eur J Pharmacol 16:120–122CrossRefPubMedGoogle Scholar
  98. Kosterlitz HW, Lydon RJ, Watt AJ (1970) The effects of adrenaline, noradrenaline and isoprenaline on inhibitory α-and β-adrenoceptors in the longitudinal muscle of the guinea-pig ileum. Br J Pharmacol 39:398–413PubMedGoogle Scholar
  99. Langer SZ (1973) The regulation of transmitter release elicited by nerve stimulation through a presynaptic feed-back mechanism. In: Usdin E, Snyder SH (eds) Frontiers in catecholamine research. Pergamon Press, New York, pp 543–549Google Scholar
  100. Langer SZ (1974) Presynaptic regulation of catecholamine release. Biochem Pharmacol 23:1793–1800CrossRefPubMedGoogle Scholar
  101. Langer SZ, Massingham R, Shepperson NB (in press) Differential sensitivity to prazosin blockade of endogenously released and exogenously administered noradrenaline: possible relationship to the synaptic location of α1-and the extrasynaptic location of α2-adrenoceptors in dog vascular smooth muscle. Br J PharmacolGoogle Scholar
  102. Lasch P, Jakobs KH (1979) Agonistic and antagonistic effects of various α-adrenergic agonists in human platelets. Naunyn Schmiedebergs Arch Pharmacol 306:119–125CrossRefPubMedGoogle Scholar
  103. Lee WH, Fujiwara M (1977) Untersuchungen zum Wirkungsmechanismus von Katecholaminen an der elektrisch gereizten isolierten Meerschweinchen-Gallenblase. Arzneim Forsch 27:1149–1152Google Scholar
  104. Lefèvre-Borg F, Roach AG, Cavero I (1978) Comparison of cardiovascular actions of dihydralazine, phentolamine, and prazosin in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1:19–29Google Scholar
  105. Leighton J, Butz KR, Parmeter LL (1979) Effect of α-adrenergic agonists and antagonists on neurotransmission in the rat anacoccygeus muscle. Eur J Pharmacol 58:27–38CrossRefPubMedGoogle Scholar
  106. Lokhandwala MF, Coats JT, Buckley JP (1977) Effects of several catecholamines on sympathetic transmission to the myocardium: role of presynaptic α-adrenoceptors. Eur J Pharmacol 42:257–265CrossRefPubMedGoogle Scholar
  107. Madjar H, Docherty JR, Starke K (1980) An examination of pre-and postsynaptic α-adrenoceptors in the autoperfused rabbit hindlimb. J Cardiovasc Pharmacol 2:619–627PubMedGoogle Scholar
  108. Malta E, McPherson GA, Raper C (1979) Comparison of pre-junctional α-adrenoceptors at the neuromuscular junction with vascular post-junctional α-receptors in cat skeletal muscle. Br J Pharmacol 65:249–256PubMedGoogle Scholar
  109. Marshall I, Nasmyth PA, Nicholl CG, Shepperson NB (1978) α-Adrenoceptors in the mouse vas deferens and their effects on its response to electrical stimulation. Br J Pharmacol 62:147–151PubMedGoogle Scholar
  110. Medgett IC, McCulloch MW, Rand MJ (1978) Partial agonist action of clonidine on prejunctional and postjunctional α-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 304:215–221CrossRefPubMedGoogle Scholar
  111. Miach PJ, Dausse JP, Meyer P (1978) Direct biochemical demonstration of two types of α-adrenoreceptor in rat brain. Nature 274:492–494CrossRefPubMedGoogle Scholar
  112. Miach PJ, Dausse JP, Cardot A, Meyer P (1980) 3H-Prazosin binds specifically to ‘α1'-adrenoceptors in rat brain. Naunyn Schmiedebergs Arch Pharmacol 312:23–26CrossRefPubMedGoogle Scholar
  113. Montel H, Starke K, Weber F (1974) Influence of morphine and naloxone on the release of noradrenaline from rat brain cortex slices. Naunyn Schmiedebergs Arch Pharmacol 283:257–269Google Scholar
  114. Morris BJ, Reid IA, Ganong WF (1979) Inhibition by α-adrenoceptor agonists of renin release in vitro. Eur J Pharmacol 59:37–45CrossRefPubMedGoogle Scholar
  115. Mouillé P, Huchet AM, Lucet B, Chelly J, Schmitt H (1979) Interactions between clonidine and α-adrenoceptor blocking drugs in the tachycardiac response to stimulation of the cardiac nerve in dogs. J Cardiovasc Pharmacol 1:515–528PubMedGoogle Scholar
  116. Mouillé P, Huchet AM, Chelly J, Lucet B, Doursout MF, Schmitt H (1980) Pharmacological properties of AR-C239, 2-[2-[4(o-methoxyphenyl)-piperazine-1-yl]-ethyl]-4,4-dimethyl-1,3(2H–4H)isoquinolinedione, a new α-adrenoceptor blocking drug. J Cardiovasc Pharmacol 2:175–191PubMedGoogle Scholar
  117. Moulds RFW, Jauernig RA (1977) Mechanism of prazosin collapse. Lancet I:200–201CrossRefGoogle Scholar
  118. Nomura Y, Oki K, Segawa T (1980) Pharmacological characterization of central α-adrenoceptors which mediate clonidine-induced locomotor hypoactivity in the developing rat. Naunyn Schmiedebergs Arch Pharmacol 311:41–44CrossRefPubMedGoogle Scholar
  119. Oberdorf A, Kroneberg G (1970) Alpha-und beta-sympathicomimetische Wirkungen am elektrisch gereizten isolierten Meerschweinchenileum. Naunyn Schmiedebergs Arch Pharmakol 267:195–207CrossRefPubMedGoogle Scholar
  120. Paton WDM, Vizi ES (1969) The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea-pig ileum longitudinal muscle strip. Br J Pharmacol 35:10–28PubMedGoogle Scholar
  121. Peroutka SJ, Greenberg DA, U'Prichard DC, Snyder SH (1978) Regional variations in alpha adrenergic receptor interactions of (3H)-dihydroergokryptine in calf brain: implications for a two-site model of alpha receptor function. Mol Pharmacol 14:403–412PubMedGoogle Scholar
  122. Pichler L, Kobinger W (1978) Presynaptic activity at peripheral adrenergic sites and blood pressure effect of α-adrenoceptor stimulating drugs. Eur J Pharmacol 52:287–295CrossRefPubMedGoogle Scholar
  123. Pichler L, Placheta P, Kobinger W (1980) Effect of azepexole (B-HT 933) on pre-and postsynaptic α-adrenoceptors at peripheral and central nervous sites. Eur J Pharmacol 65:233–241CrossRefPubMedGoogle Scholar
  124. Puech AJ, Lecrubier Y, Simon P (1979) Are alpha and beta presynaptic receptors involved in mood regulation? Pharmacological and clinical data. In: Langer SZ, Starke K, Dubocovich ML (eds) Presynaptic receptors. Pergamon Press, Oxford, pp 359–362Google Scholar
  125. Rand MJ, McCulloch MW, Story DF (1975) Pre-junctional modulation of noradrenergic transmission by noradrenaline, dopamine and acetylcholine. In: Davies DS, Reid JL (eds) Central action of drugs in blood pressure regulation. Pitman, Tunbridge Wells, pp 94–132Google Scholar
  126. Reynoldson JA, Head GA, Korner PI (1979) Effect of 6-hydroxydopamine on blood pressure and heart rate responses to intracisternal clonidine in conscious rabbits. Eur J Pharmacol 55:257–262CrossRefPubMedGoogle Scholar
  127. Rhodes KF, Waterfall JF (1978) Pre-and postsynaptic α-adrenoceptor antagonism by indoramin in isolated tissues of the rat. J Pharm Pharmacol 30:516–517PubMedGoogle Scholar
  128. Roach AG, Lefevre F, Cavero I (1978) Effects of prazosin and phentolamine on cardiac presynaptic α-adrenoceptors in the cat, dog and rat. Clin Exp Hypertension 1:87–101Google Scholar
  129. Robson RD, Antonaccio MJ, Saelens JK, Liebman J (1978) Antagonism by mianserin and classical α-adrenoceptor blocking drugs of some cardiovascular and behavioral effects of clonidine. Eur J Pharmacol 47:431–442CrossRefPubMedGoogle Scholar
  130. Rossi EC, Louis G, Zeller EA (1979) Structure activity relationships between catecholamines and the α-adrenergic receptor responsible for the aggregation of human platelets by epinephrine. J Lab Clin Med 93:286–294PubMedGoogle Scholar
  131. Rouot BM, U'Prichard DC, Snyder SH (1980) Multiple α2-noradrenergic receptor sites in rat brain: selective regulation of high-affinity (3H)clonidine binding by guanine nucleotides and divalent cations. J Neurochem 34:374–384PubMedGoogle Scholar
  132. Ruffolo RR, Turowski BS, Patil PN (1977) Lack of cross-desensitization between structurally dissimilar α-adrenoceptor agonists. J Pharm Pharmacol 29:378–380PubMedGoogle Scholar
  133. Ruffolo RR, Rosing EL, Waddell JE (1979) Receptor interactions of imidazolines. I. Affinity and efficacy for alpha adrenergic receptors in rat aorta. J Pharmacol Exp Ther 209:429–436PubMedGoogle Scholar
  134. Scatton B, Pelayo F, Dubocovich ML, Langer SZ, Bartholini G (1979) Effect of clonidine on utilization and potassium-evoked release of adrenaline in rat brain areas. Brain Res 176:197–201CrossRefPubMedGoogle Scholar
  135. Schmitt H (1977) The pharmacology of clonidine and related products. In: Gross F (ed) Antihypertensive agents. Springer, Berlin Heidelberg New York, pp 299–396Google Scholar
  136. Schmitt H, Schmitt H, Fenard S (1971) Evidence for an α-sympathomimetic component in the effects of catapresan on vasomotor centres: antagonism by piperoxane. Eur J Pharmacol 14:98–100CrossRefPubMedGoogle Scholar
  137. Scholtysik G, Lauener H, Eichenberger E, Bürki H, Salzmann R, Müller-Schweinitzer E, Waite R (1975) Pharmacological actions of the antihypertensive agent N-amidino-2-(2,6-dichlorophenyl)acetamide hydrochloride (BS 100–141). Arzneim Forsch 25:1483–1491Google Scholar
  138. Seno N, Nakazato Y, Ohga A (1978) Presynaptic inhibitory effects of catecholamines on cholinergic transmission in the smooth muscle of the chick stomach. Eur J Pharmacol 51:229–237CrossRefPubMedGoogle Scholar
  139. Starke K (1972) Alpha sympathomimetic inhibition of adrenergic and cholinergic transmission in the rabbit heart. Naunyn Schmiedebergs Arch Pharmacol 274:18–45CrossRefPubMedGoogle Scholar
  140. Starke K (1977) Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 77:1–124PubMedGoogle Scholar
  141. Starke K, Langer SZ (1979) A note on terminology for presynaptic receptors. In: Langer SZ, Starke K, Dubocovich ML (eds) Presynaptic receptors. Pergamon Press, Oxford, pp 1–3Google Scholar
  142. Starke K, Montel H, Gayk W, Merker R (1974) Comparison of the effects of clonidine on pre-and postsynaptic adrenoceptors in the rabbit pulmonary artery. Naunyn Schmiedebergs Arch Pharmacol 285:133–150CrossRefPubMedGoogle Scholar
  143. Starke K, Borowski E, Endo T (1975a) Preferential blockade of presynaptic α-adrenoceptors by yohimbine. Eur J Pharmacol 34:385–388CrossRefPubMedGoogle Scholar
  144. Starke K, Endo T, Taube HD (1975b) Relative pre-and postsynaptic potencies of α-adrenoceptor agonists in the rabbit pulmonary artery. Naunyn Schmiedebergs Arch Pharmacol 291:55–78CrossRefPubMedGoogle Scholar
  145. Starke K, Taube HD, Borowski E (1977) Presynaptic receptor systems in catecholaminergic transmission. Biochem Pharmacol 26:259–268CrossRefPubMedGoogle Scholar
  146. Steinsland OS, Hieble JP (1979) Activities of structural analogues of dopamine on prejunctional dopaminergic and alpha adrenergic receptors. In: Langer SZ, Starke K, Dubocovich ML (eds) Presynaptic receptors. Pergamon Press, Oxford, pp 93–98Google Scholar
  147. Stephenson RP (1956) A modification of receptor theory. Br J Pharmacol 11:379–393Google Scholar
  148. Steppeler A, Tanaka T, Starke K (1978) A comparison of pre-and postsynaptic α-adrenergic effects of phenylephrine and tramazoline on blood vessels of the rabbit in vivo. Naunyn Schmiedebergs Arch Pharmacol 304:223–230CrossRefPubMedGoogle Scholar
  149. Stjärne L (1975) Clonidine enhances the secretion of sympathetic neurotransmitter from isolated guinea-pig tissues. Acta Physiol Scand 93:142–144PubMedGoogle Scholar
  150. Story DD, Briley MS, Langer SZ (1979) The effects of chemical sympathectomy with 6-hydroxydopamine on α-adrenoceptor and muscarinic cholinoceptor binding in rat heart ventricle. Eur J Pharmacol 57:423–426CrossRefPubMedGoogle Scholar
  151. Strömbom U, Svensson TH (1980) Clonidine: attenuation of sedative action by facilitated central noradrenergic neurotransmission. J Neural Transmission 47:29–39CrossRefGoogle Scholar
  152. Tanaka T, Starke K (1979) Binding of 3H-clonidine to an α-adrenoceptor in membranes of guinea-pig ileum. Naunyn Schmiedebergs Arch Pharmacol 309:207–215CrossRefPubMedGoogle Scholar
  153. Tanaka T, Starke K (1980) Antagonist-/agonist-preferring α-adrenoceptors or α12 adrenoceptors? Eur J Pharmacol 63:191–194CrossRefPubMedGoogle Scholar
  154. Taube HD, Starke K, Borowski E (1977) Presynaptic receptor systems on the noradrenergic neurones of rat brain. Naunyn Schmiedebergs Arch Pharmacol 299:123–141CrossRefPubMedGoogle Scholar
  155. Timmermans PBMWM, van Zwieten PA (1980) Postsynaptic α1-and α2-adrenoceptors in the circulatory system of the pithed rat: selective stimulation of the α2-type by B-HT 933. Eur J Pharmacol 63:199–202CrossRefPubMedGoogle Scholar
  156. Timmermans PBMWM, Kwa HY, van Zwieten PA (1979a) Possible subdivision of post-synaptic α-adrenoceptors mediating pressor responses in the pithed rat. Naunyn Schmiedebergs Arch Pharmacol 310:189–193CrossRefPubMedGoogle Scholar
  157. Timmermans PBMWM, Lam E, van Zwieten PA (1979b) The interaction between prazosin and clonidine at α-adrenoceptors in rats and cats. Eur J Pharmacol 55:57–66CrossRefPubMedGoogle Scholar
  158. Tsai BS, Lefkowitz RJ (1978) Agonist-specific effects of monovalent and divalent cations on adenylate cyclase-coupled alpha adrenergic receptors in rabbit platelets. Mol Pharmacol 14:540–548PubMedGoogle Scholar
  159. Tsai BS, Lefkowitz RJ (1979) Agonist-specific effects of guanine nucleotides on alpha-adrenergic receptors in human platelets. Mol Pharmacol 16:61–68PubMedGoogle Scholar
  160. U'Prichard DC, Snyder SH (1977) Binding of 3H-catecholamines to α-noradrenergic receptor sites in calf brain. J Biol Chem 252:6450–6463PubMedGoogle Scholar
  161. U'Prichard DC, Snyder SH (1978) Guanyl nucleotide influences on 3H-ligand binding to α-noradrenergic receptors in calf brain membranes. J Biol Chem 253:3444–3452PubMedGoogle Scholar
  162. U'Prichard DC, Snyder SH (1979) Distinct α-noradrenergic receptors differentiated by binding and physiological relationships. Life Sci 24:79–88CrossRefPubMedGoogle Scholar
  163. U'Prichard DC, Greenberg DA, Snyder SH (1977) Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors. Mol Pharmacol 13:454–473PubMedGoogle Scholar
  164. U'Prichard DC, Charness ME, Robertson D, Snyder SH (1978) Prazosin: differential affinities for two populations of α-noradrenergic receptor binding sites. Eur J Pharmacol 50:87–89CrossRefPubMedGoogle Scholar
  165. Vizi ES (1979) Presynaptic modulation of neurochemical transmission. Prog Neurobiol 12:181–290CrossRefPubMedGoogle Scholar
  166. Walland A (1978) Inhibition of a somato-sympathetic reflex via peripheral presynaptic α-adrenoceptors. Eur J Pharmacol 47:211–221CrossRefPubMedGoogle Scholar
  167. Waud DR (1968) Pharmacological receptors. Pharmacol Rev 20:49–88PubMedGoogle Scholar
  168. Weitzell R, Tanaka T, Starke K (1979) Pre-and postsynaptic effects of yohimbine stereoisomers on noradrenergic transmission in the pulmonary artery of the rabbit. Naunyn Schmiedebergs Arch Pharmacol 308:127–136CrossRefPubMedGoogle Scholar
  169. Westfall TC (1977) Local regulation of adrenergic neurotransmission. Physiol Rev 57:659–728PubMedGoogle Scholar
  170. Wikberg J (1978a) Differentiation between pre-and postjunctional α-receptors in guinea pig ileum and rabbit aorta. Acta Physiol Scand 103:225–239PubMedGoogle Scholar
  171. Wikberg JES (1978b) Pharmacological classification of adrenergic α receptors in the guinea pig. Nature 273:164–166CrossRefPubMedGoogle Scholar
  172. Wikberg JES (1979a) Pre-and postjunctional α-receptors. In: Langer SZ, Starke K, Dubocovich ML (eds) Presynaptic receptors. Pergamon Press, Oxford, pp 117–123Google Scholar
  173. Wikberg JES (1976b) The pharmacological classification of adrenergic α1 and α2 receptors and their mechanisms of action. Acta Physiol Scand Suppl 468Google Scholar
  174. Wikberg J, Andersson R, Lundholm L (1975) Differentation of adrenergic α-receptors in guinea pig in testine and rabbit aorta. Blood Vessels 12:383–384Google Scholar
  175. Wood CL, Amett CD, Clarke WR, Tsai BS, Lefkowitz RJ (1979) Subclassification of alpha-adrenergic receptors by direct binding studies. Biochem Pharmacol 28:1277–1282CrossRefPubMedGoogle Scholar
  176. Young WS, Kuhar MJ (1979) Noradrenergic α1 and α2 receptors: autoradiographic visualization. Eur J Pharmacol 59:317–319CrossRefPubMedGoogle Scholar
  177. Zebrowska-Lupina I, Przegalinski E, Sloniec M, Kleinrok Z (1977) Clonidine-induced locomotor hyperactivity in rats. Naunyn Schmiedebergs Arch Pharmacol 297:227–231CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 1981

Authors and Affiliations

  • Klaus Starke
    • 1
  1. 1.Pharmakologisches Institut, Universität FreiburgFreiburg i.B.

Personalised recommendations